Eyeworld CME Supplements

EW OCT 2015 - Supported by unrestricted educational grants from Alcon Laboratories and Bausch + Lomb

This is a supplement to EyeWorld Magazine that doctors can take a test after reading and receive CME credits for.

Issue link: http://cmesupplements.eyeworld.org/i/586314

Contents of this Issue

Navigation

Page 0 of 7

Supplement to EyeWorld October 2015 Crossing the finish line: Launching your premium technology practice Supported by unrestricted educational grants from Alcon Laboratories and Bausch + Lomb. Accreditation Statement This activity has been planned and implement- ed in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the American Society of Cataract & Refractive Surgery (ASCRS) and EyeWorld. ASCRS is accred- ited by the ACCME to provide continuing medical education for physicians. Educational Objectives Ophthalmologists who participate in this activity will: • Establish protocols for exposing young ophthalmologists to LACS and identify the clinical benefits and practice implications of the growing use of femtosecond laser assistance in cataract surgery; • Recognize the visual quality performance of premium IOLs, particularly with advanced presbyopia-correcting and toric IOLs, with regard to both clinical outcomes and practice performance and the importance of incorporat- ing these technologies for new and established refractive cataract practices; and • Describe the latest evolutions in refractive surgery as a new paradigm for ophthalmol- ogists and the benefits and implications this technology has for patient care and establish- ing a modern cataract and refractive practice. Designation Statement The American Society of Cataract & Refractive Surgery designates this enduring materials educational activity for a maximum of 1.0 AMA PRA Category 1 Credits. ™ Physicians should claim only credit commensurate with the extent of their participation in the activity. Claiming Credit To claim credit, participants must visit bit.ly/1QmyvcW to review content and download the post-activity test and credit claim. All par- ticipants must pass the post-activity test with a score of 75% or higher to earn credit. Alternative- ly, the post-test form included in this supplement may be faxed to the number indicated for credit to be awarded, and a certificate will be mailed within 2 weeks. When viewing online or down- loading the material, standard Internet access is required. Adobe Acrobat Reader is needed to view the materials. CME credit is valid through April 30, 2016. CME credit will not be awarded after that date. Notice of Off-Label Use Presentations This activity may include presentations on drugs or devices or uses of drugs or devices that may not have been approved by the Food and Drug Administration (FDA) or have been approved by the FDA for specific uses only. ADA/Special Accommodations ASCRS and EyeWorld fully comply with the legal requirements of the Americans with Disabilities Act (ADA) and the rules and regulations thereof. Any participant in this educational program who requires special accommodations or services should contact Laura Johnson at ljohnson@ascrs. org or 703-591-2220. Financial Interest Disclosures John Berdahl MD, has received a retainer, ad hoc fees or other consulting income from and is a member of the speakers bureau of Alcon Laboratories Inc., Allergan, Avedro Inc., Glaukos Corporation, and Omega Ophthalmics. Dr. Berdahl has received a retainer, ad hoc fees or other con- sulting income from Abbott Medical Optics Inc. and ClarVista. He received research funding from Alcon Laboratories Inc. and Glaukos Corporation. Dr. Berdahl has an investment interest in Avedro Inc. and Omega Ophthalmics and has received travel expense reimbursement from Alcon Laboratories Inc. Kendall E. Donaldson, MD, has no ophthalmic- related financial interests to disclose. Sumit "Sam" Garg, MD, has received a retainer, ad hoc fees or other consulting income from Abbott Medical Optics Inc. and is a member of the speakers bureau of Allergan. Bonnie An Henderson, MD, has received a retainer, ad hoc fees or other consulting income from Alcon Laboratories Inc. and Bausch + Lomb. She is a member of the speakers bureaus of Abbott Medical Optics Inc. and Genzyme. William B. Trattler, MD, has received a retainer, ad hoc fees or other consulting income from: Abbott Medical Optics Inc., Alcon Laboratories Inc., Allergan, Bausch + Lomb, CXL Ophthalmics LLC, Imprimis Pharmaceuticals, and Omeros Corporation. He is a member of the speakers bureaus of: Abbott Medial Optics Inc., Allergan, Bausch + Lomb, and Oculus. Dr. Trattler has received research funding from Alcon Laborato- ries Inc. and Refocus Group Inc. He has received travel expense reimbursement from Alcon Laboratories Inc. Elizabeth Yeu, MD, has received a retainer, ad hoc fees or other consulting income from: Abbott Medical Optics Inc., Alcon Laboratories Inc., Aller- gan, Bausch + Lomb, TearLab, and TearScience. She is a member of the speakers bureaus of: Alcon Laboratories Inc., Allergan, and BioTissue. Dr. Yeu has an investment interest in RPS. Staff member disclosures: Laura Johnson has no ophthalmic-related financial interests. Jan Beiting has received a retainer, ad hoc fees or other consulting income from AcuFocus, Abbott Medical Optics, Iridex, Johnson & Johnson Vision Care Inc., TearScience, and WaveTec Vision Systems. by Bonnie An Henderson, MD Young eye surgeons start out with limited premium technology experience We know that barriers to per- forming laser-assisted cataract sur- gery (LACS) exist across age groups, with financial concerns and lack of access to the technology leading the list of reasons why surgeons haven't yet performed LACS. Each of these technologies can be beneficial to patient care. More- over, as concerns about the future of Medicare reimbursement rise, they may also be critical to maintaining a healthy practice. In this supplement we share advice from successful young physi- cians on how to launch an advanced technology practice, as well as some great toric, multifocal, and accom- modating IOL cases and discussion around how to succeed with these IOLs in clinical practice. Dr. Henderson is clinical professor at Tufts University School of Medicine and a partner at Ophthalmic Consultants of Boston. She can be contacted at bahenderson@eyeboston.com. W e know that gaining access to and experi- ence with advanced technology can be challenging for young ophthalmologists, the majority of whom say their exposure to premi- um technology in residency is inade- quate. According to the 2014 ASCRS Clinical Survey, two-thirds (63%) of those in residency, fellowship or their first 5 years in practice say they had no formal refractive surgery training during residency. Experience with premium IOLs and corneal relaxing incisions is also very limited, with most young ophthalmologists saying they have performed 5 or fewer cases (Figure 1). Figure 1: According to the 2014 ASCRS Clinical Survey, most young physicians have limited experience with LRIs and toric and presbyopia-correcting IOLs. Young Physicians: Premium IOLs and CRIs Experience with this technology is limited to <5 cases Most young physicians surveyed have implanted 5 or fewer premium IOLs Toric IOLs Presbyopia- correcting IOLs Corneal relaxing incisions 70 60 50 40 30 20 10 0 43% 66% 63% Bonnie An Henderson, MD Click to read and claim CME credit

Articles in this issue

Links on this page

Archives of this issue

view archives of Eyeworld CME Supplements - EW OCT 2015 - Supported by unrestricted educational grants from Alcon Laboratories and Bausch + Lomb